









Markets
/
Stocks
/
nasdaq-clov
/

Clover Health Investments Corp

CLOV

3.530USD

+0.060+1.73%

Close 10/31, 16:00（ET）Quotes delayed by 15 min

1.80BMarket Cap

LossP/E TTM



Clover Health Investments Corp

3.530

+0.060+1.73%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Clover Health Investments Corp

Currency: USD Updated: 2025-10-30

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. The company is performing strongly in the stock market, with strong fundamentals and technicals supporting the momentum. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Clover Health Investments Corp's Score

Industry at a Glance

Industry Ranking

34 / 78

Overall Ranking

163 / 4621

Industry

Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 3 analysts

Hold

Current Rating

3.367

Target Price

-7.51%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Clover Health Investments Corp Highlights

StrengthsRisks

Clover Health Investments, Corp. is a physician-enablement technology company. The Company is focused on bringing access to healthcare to everyone on Medicare. This includes a health equity-based focus on seniors, who have historically lacked access to affordable healthcare. It offers a software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. The Company, through its Insurance segment, provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. For healthcare providers outside its MA plan, it focuses on extending the benefits of its data-driven technology platform to a wider audience via its subsidiary, Counterpart Health, Inc.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 25.04% year-on-year.

Undervalued

The company’s latest PE is -39.91, at a low 3-year percentile range.

Institutional Buying

The latest institutional holdings are 147.75M shares, increasing 18.99% quarter-over-quarter.

Held by Joel Greenblatt

Star Investor Joel Greenblatt holds 105.60K shares of this stock.

Financial Health

Currency: USD Updated: 2025-10-30

The company's current financial score is 7.60, which is higher than the Healthcare Providers & Services industry's average of 7.24. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 477.62M, representing a year-over-year increase of 34.07%, while its net profit experienced a year-over-year increase of 242.79%.

Score

Industry at a Glance

Previous score

7.60

Change



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

6.05

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

7.31

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

7.88

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

6.74

Key Metrics

Free cash flow

No Data

Clover Health Investments Corp's Company Valuation

Currency: USD Updated: 2025-10-30

The company’s current valuation score is 8.15, which is higher than the Healthcare Providers & Services industry's average of 7.09. Its current P/E ratio is -39.91, which is -97.41% below the recent high of -1.03 and -85.50% above the recent low of -74.04.

Score

Industry at a Glance

Previous score

8.15

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 34/78

No Data

Earnings Forecast

Currency: USD Updated: 2025-10-30

The company’s current earnings forecast score is 7.00, which is lower than the Healthcare Providers & Services industry's average of 7.60. The average price target for Clover Health Investments Corp is 3.00, with a high of 4.10 and a low of 3.00.

Score

Industry at a Glance

Previous score

7.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 3 analysts

Hold

Current Rating

3.367

Target Price

-2.98%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Clover Health Investments Corp

CLOV

Humana Inc

HUM

UnitedHealth Group Inc

UNH

Cigna Group

Elevance Health Inc

ELV

Centene Corp

CNC

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-10-30

The company’s current price momentum score is 9.25, which is higher than the Healthcare Providers & Services industry's average of 6.80. Sideways: Currently, the stock price is trading between the resistance level at 4.11 and the support level at 2.64, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

9.47

Change

-0.22

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(2)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

0.134

Buy

RSI(14)

61.235

Neutral

STOCH(KDJ)(9,3,3)

67.028

Sell

ATR(14)

0.234

Low Volatility

CCI(14)

49.637

Neutral

Williams %R

28.467

Buy

TRIX(12,20)

1.034

Sell

StochRSI(14)

10.640

Oversold

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

3.642

Sell

MA10

3.445

Buy

MA20

3.070

Buy

MA50

2.964

Buy

MA100

2.892

Buy

MA200

3.323

Buy

Institutional Confidence

Currency: USD Updated: 2025-10-30

The company’s current institutional recognition score is 3.00, which is lower than the Healthcare Providers & Services industry's average of 6.96. The latest institutional shareholding proportion is 35.17%, representing a quarter-over-quarter increase of 6.60%. The largest institutional shareholder is The Vanguard, holding a total of 24.15M shares, representing 5.75% of shares outstanding, with 22.18% increase in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

26.81M

+219.81%

The Vanguard Group, Inc.

Star Investors

24.15M

+17.90%

Renaissance Technologies LLC

Star Investors

10.49M

-4.81%

Geode Capital Management, L.L.C.

9.84M

+95.65%

State Street Investment Management (US)

7.51M

+156.51%

PNC Investments LLC

4.46M

-0.11%

BofA Global Research (US)

4.01M

+217.47%

Charles Schwab Investment Management, Inc.

3.89M

+49.13%

Citadel Advisors LLC

3.53M

+103.60%

Marshall Wace LLP

3.52M

-23.00%

Risk Assessment

Currency: USD Updated: 2025-10-30

The company’s current risk assessment score is 4.20, which is lower than the Healthcare Providers & Services industry's average of 5.45. The company's beta value is 2.09. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.